(Q45747421)

15 December 2017

title

Hepatoma-specific antitumor activity of an albumin enhancer/promoter regulated herpes simplex virus in vivo (English)

1 reference

15 December 2017

author

Hiroki Toda

5

1 reference

15 December 2017

author name string

Miyatake SI

1

1 reference

15 December 2017

Tani S

2

1 reference

15 December 2017

Feigenbaum F

3

1 reference

15 December 2017

Sundaresan P

4

1 reference

15 December 2017

Narumi O

6

1 reference

15 December 2017

Kikuchi H

7

1 reference

15 December 2017

Hashimoto N

8

1 reference

15 December 2017

Hangai M

9

1 reference

15 December 2017

Martuza RL

10

1 reference

15 December 2017

Rabkin SD

11

1 reference

15 December 2017

publication date

1 April 1999

1 reference

15 December 2017

published in

Gene Therapy

1 reference

15 December 2017

volume

6

1 reference

15 December 2017

page(s)

564-572

1 reference

15 December 2017

issue

4

1 reference

15 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3300861

exact match

0 references

cites work

Cytokines and clinical gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

Cytokines, tumour-cell death and immunogenicity: a question of choice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

Tissue-specific targeting of retroviral vectors through ligand-receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

Current treatment modalities for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

Nonresectional therapies for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

Reduction and elimination of encephalitis in an experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

Treatment of experimental intracranial murine melanoma with a neuroattenuated herpes simplex virus 1 mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

A novel multiply-mutated HSV-1 strain for the treatment of human brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

The herpes simplex virus 1 protein kinase US3 is required for protection from apoptosis induced by the virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

Virulence of and establishment of latency by genetically engineered deletion mutants of herpes simplex virus 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

Transcriptional and post-transcriptional control of specific messenger RNAs in adult and embryonic liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

Spontaneous metastasis of cells of the human prostate carcinoma cell line PC-3 in athymic nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

Enhancement of gene therapy specificity for diffuse colon carcinoma liver metastases with recombinant herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

Long-term survival in a rodent model of disseminated brain tumors by combined intrathecal delivery of herpes vectors and ganciclovir treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

Ribonucleotide reductase encoded by herpes simplex virus is a determinant of the pathogenicity of the virus in mice and a valid antiviral target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

The Pathogenicity of Ribonucleotide Reductase-Null Mutants of Herpes Simplex Virus Type 1 in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

Herpes simplex virus type 1 ribonucleotide reductase null mutants induce lesions in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

Enhanced and specific gene expression via tissue-specific production of Cre recombinase using adenovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

Analysis of alpha-fetoprotein gene expression in hepatocellular carcinoma and liver cirrhosis by in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

Detection of alpha-foetoprotein messenger RNA in human hepatocellular carcinoma and hepatoblastoma tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

Induction of both thymidine and deoxycytidine kinase activity by herpes viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

Mutant herpes simplex virus induced regression of tumors growing in immunocompetent rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

Role of Herpes simplex Virus Thymidine Kinase Expression in Viral Pathogenesis and Latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

Construction of a US3 lacZ insertion mutant of herpes simplex virus type 2 and characterization of its phenotype in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

Herpes Simplex Virus Hepatitis after Solid Organ Transplantation in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

Herpes simplex virus hepatitis: case report and review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

Activities of herpes simplex virus type 1 (HSV-1) ICP4 genes specifying nonsense peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

21 January 2018

Gene therapy for cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

7 January 2021

Targeted vectors for gene therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

7 January 2021

A Potential Approach for Gene Therapy Targeting Hepatoma Using a Liver-Specific Promoter on a Retroviral Vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

7 January 2021

Transcriptional targeting of herpes simplex virus for cell-specific replication

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

7 January 2021

Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

7 January 2021

Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: isolation and characterization of an ICP6 lacZ insertion mutant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

7 January 2021

Differential regulation of endogenous and transduced beta-globin genes during infection of erythroid cells with a herpes simplex virus type 1 recombinant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

7 January 2021

Alpha-fetoprotein in ontogenesis and its association with malignant tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300861

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3300861

1 reference

15 December 2017

Dimensions Publication ID

0 references

1 reference

15 December 2017